The predictive ability of serum α‐fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance
Background Serum α‐fetoprotein (AFP) is the most important tumor marker for
hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP for HCC widely …
hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP for HCC widely …
[HTML][HTML] Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of …
KY Lin, QJ Chen, SC Tang, ZW Lin, JX Zhang… - BMC cancer, 2023 - Springer
Background Routine clinical staging for hepatocellular carcinoma (HCC) incorporates liver
function, general health, and tumor morphology. Further refinement of prognostic …
function, general health, and tumor morphology. Further refinement of prognostic …
Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation
A Nörthen, T Asendorf, PD Walson, M Oellerich - Clinical biochemistry, 2018 - Elsevier
Abstract Background Alpha-1-fetoprotein (AFP) is used to monitor progression, evaluate
response to therapy and predict recurrence of hepatocellular carcinoma (HCC) in liver …
response to therapy and predict recurrence of hepatocellular carcinoma (HCC) in liver …
[HTML][HTML] Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy
J Zhang, SD Qin, Y Li, F Lu, WF Gong… - World Journal of …, 2022 - Springer
Background The prognosis of hepatocellular carcinoma (HCC) varies considerably among
patients with the same disease stage and characteristics, and only about two thirds show …
patients with the same disease stage and characteristics, and only about two thirds show …
[HTML][HTML] Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology–a prospective study
SR Chaminda, T Suchintha, NM Anuk, DA Supun… - BMC …, 2017 - Springer
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …
[HTML][HTML] Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor
E Vibert, D Azoulay, E Hoti, S Iacopinelli… - American Journal of …, 2010 - Elsevier
Liver transplantation (LT) for cirrhotic/Hepatocellular carcinoma (HCC) is associated with
reduced survival in patients with poor histological features. Preoperative levels of …
reduced survival in patients with poor histological features. Preoperative levels of …
[PDF][PDF] Serum alpha‐fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma
K Berry, GN Ioannou - Liver Transplantation, 2013 - Wiley Online Library
We aimed to determine whether combining serum alpha‐fetoprotein (AFP) level with
hepatocellular carcinoma (HCC) tumor burden would allow better stratification of …
hepatocellular carcinoma (HCC) tumor burden would allow better stratification of …
The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome
Background The postresection alpha-fetoprotein (AFP) in cirrhotic patients with
hepatocellular carcinoma (HCC) may predict overall survival (OS) and recurrence beyond …
hepatocellular carcinoma (HCC) may predict overall survival (OS) and recurrence beyond …
[HTML][HTML] Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review
WC Chou, CL Lee, TS Yang, CY Huang, W Teng… - Journal of the Formosan …, 2018 - Elsevier
Background Oxaliplatin-based chemotherapy is an alternative systemic treatment for
patients with metastatic hepatocellular carcinoma (HCC) who were refractory or intolerant to …
patients with metastatic hepatocellular carcinoma (HCC) who were refractory or intolerant to …
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment
Y Tamura, T Suda, S Arii, M Sata, F Moriyasu… - Digestive diseases and …, 2013 - Springer
Background The fucosylated fraction of alpha-fetoprotein (AFP-L3) has been used as a
diagnostic marker for hepatocellular carcinoma (HCC). Recently, a highly sensitive …
diagnostic marker for hepatocellular carcinoma (HCC). Recently, a highly sensitive …